Literature DB >> 10452752

Fractional analysis of sequential induced sputum samples during sputum induction: evidence that different lung compartments are sampled at different time points.

N H Gershman1, H Liu, H H Wong, J T Liu, J V Fahy.   

Abstract

BACKGROUND: The effect of the duration of sputum induction on markers of inflammation in induced sputum is unknown, and the optimal duration of sputum induction for research purposes in airway disease is uncertain.
OBJECTIVE: We sought to determine whether the duration of sputum induction influences the cellular or biochemical characteristics of induced sputum.
METHODS: Induced sputum was collected sequentially at 4-minute intervals during a 20-minute sputum induction in 12 subjects with mild and moderate asthma. Each 4-minute sample was collected and analyzed separately for total and differential cell counts and for levels of eosinophil cationic protein, fibrinogen, mucin-like glycoprotein, and surfactant protein SP-A.
RESULTS: The percentages of eosinophils and neutrophils were significantly higher at the beginning of the 20-minute sputum induction than at the end, whereas the percentage of macrophages was significantly lower at the beginning than at the end. In addition, the levels of eosinophil cationic protein and mucin-like glycoprotein were significantly higher at the beginning of the 20-minute induction than at the end, whereas the level of surfactant protein SP-A was significantly lower.
CONCLUSIONS: The duration of sputum induction significantly affects the cellular and biochemical composition of induced sputum in a manner suggesting that large airways are sampled at the beginning of sputum induction, whereas peripheral airways and alveoli are sampled at later time periods. Our data demonstrate the importance of standardizing the duration of sputum induction in clinical research studies, and on the basis of these data, we have chosen 12 minutes as the optimal duration for sputum induction in asthmatic subjects.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10452752     DOI: 10.1016/s0091-6749(99)70374-x

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  17 in total

1.  Sputum tobramycin concentrations in cystic fibrosis patients with repeated administration of inhaled tobramycin.

Authors:  Jennifer Ruddy; Julia Emerson; Richard Moss; Alan Genatossio; Sharon McNamara; Jane L Burns; Gail Anderson; Margaret Rosenfeld
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2012-05-23       Impact factor: 2.849

2.  Extrafine HFA-beclomethasone dipropionate versus budesonide for asthma: a meta-analysis.

Authors:  Xin Chen; Yingbo Kang; Liqing Wang; Lin Lin; Zhe Zhu; Rui Chen
Journal:  Int J Clin Exp Med       Date:  2015-01-15

3.  Relationship of airway wall thickening to an imbalance between matrix metalloproteinase-9 and its inhibitor in asthma.

Authors:  H Matsumoto; A Niimi; M Takemura; T Ueda; M Minakuchi; R Tabuena; K Chin; T Mio; Y Ito; S Muro; T Hirai; S Morita; S Fukuhara; M Mishima
Journal:  Thorax       Date:  2005-04       Impact factor: 9.139

4.  Methods for Extraction and Detection of Pf Bacteriophage DNA from the Sputum of Patients with Cystic Fibrosis.

Authors:  Elizabeth B Burgener; Patrick R Secor; Michael C Tracy; Johanna M Sweere; Elisabeth M Bik; Carlos E Milla; Paul L Bollyky
Journal:  Phage (New Rochelle)       Date:  2020-06-16

5.  Sputum induction as a research tool for sampling the airways of subjects with cystic fibrosis.

Authors:  N R Henig; M R Tonelli; M V Pier; J L Burns; M L Aitken
Journal:  Thorax       Date:  2001-04       Impact factor: 9.139

6.  Determining cystic fibrosis-affected lung microbiology: comparison of spontaneous and serially induced sputum samples by use of terminal restriction fragment length polymorphism profiling.

Authors:  Geraint B Rogers; Stuart Skelton; David J Serisier; Christopher J van der Gast; Kenneth D Bruce
Journal:  J Clin Microbiol       Date:  2009-11-11       Impact factor: 5.948

7.  Effects of hydrofluoroalkane and dry powder-formulated corticosteroids on sputum inflammatory markers in asthmatic patients.

Authors:  H Hauber; Rame Taha; Celine Bergeron; Vladimir Migounov; Qutayba Hamid; Ron Olivenstein
Journal:  Can Respir J       Date:  2006-03       Impact factor: 2.409

8.  Is Induced Sputum A Useful Noninvasive Tool in the Diagnosis of Pulmonary Sarcoidosis?

Authors:  Ayşe Baha; Fatma Yıldırım; Moshe Stark; Ayşe Kalkancı; Elizabeth Fireman; Nurdan Köktürk
Journal:  Turk Thorac J       Date:  2019-08-19

9.  Beclomethasone/formoterol fixed combination for the management of asthma: patient considerations.

Authors:  Gabriele Nicolini; Nicola Scichilone; Andrea Bizzi; Alberto Papi; Leonardo M Fabbri
Journal:  Ther Clin Risk Manag       Date:  2008-10       Impact factor: 2.423

10.  Altered microRNA signatures in sputum of patients with active pulmonary tuberculosis.

Authors:  Zhengjun Yi; Yurong Fu; Rui Ji; Ruifang Li; Zhiyu Guan
Journal:  PLoS One       Date:  2012-08-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.